De Rhodiola rosea wordt al eeuwenlang medicinaal gebruikt. Het beschikt als adaptogeen over werkzaamheid bij het verbeteren van de stemming, mentale weerbaarheid, algehele vitaliteit en uithoudingsvermogen, zo blijkt uit vele onderzoeken.
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Auteur
Verschenen in
Referenties
Panossian A, Wagner H. A review of their history, biological activity and clinical benefits. The Journal of the American Botanical Council 90: 52–63, 2011
Panossian A, Wikman G, Wagner H. Plant adaptogens III: earlier and more recent aspects and concepts on their modes of action. Phytomedicine 6: 287–300, 1999
Panossian A, Wikman G, Sarris J. Rosenroot: Traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine, 2010
Kelly GS. Rhodiola rosea: A Possible Plant Adaptogen. Alternative Medicine Review 6(3), 2001
Rohloff J. Volatiles from rhizomes of Rhodiola rosea L. Phytochemistry 59: 655–661, 2002
Morgan M and Bone K. Rhodiola rosea. MediHerb, a phytotherapist’s perspective 47, 2005
Brown RP et al. Rhodiola rosea: A Phytomedicinal Overview. The Journal of the American Botanical Council 56: 40-52, 2002
Kurkin VA, Zapesochnaya GG. Chemical composition and pharmacological properties of Rhodiola rosea. Chemical and Pharmaceutical Journal 20(10): 1231-44, 1986
Stancheva SL, Mosharrof A. Effect of the extract of Rhodiola rosea L. on the content of the brain biogenic monamines. Med Physiol 40: 85-87, 1987
Panossian AG. Adaptogens in Mental and Behavioral Disorders Psychiatr Clin N Am 36: 49–64, 2013
Guo N et al. The metabolism of salidroside to its aglycone p-tyrosol in rats following the administration of salidroside. PLoS ONE 9(8), 2014
Panossian A et al. Mechanism of action of Rhodiola, salidroside, tyrosol and triandrin inisolated neuroglial cells: An interactive pathway analysis of the downstream effects using RNA microarray data. Phytomedicine 21: 1325–1348, 2014
Spasov AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin VV. A doubleblind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract fatigue of student caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine 7(2): 85–9, 2000
Mao JJ. Et al. Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo -controlled trial. Phytomedicine 22: 394–399, 2015
Darbinyan V, Aslanyan G, Amroyan E, Gabrielyan E, Malmstrom C, Panossian A. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nord J Psychiatry 61: 343-348, 2007
Edwards D, Heufelder A and Zimmerman A. Therapeutic effects and safety of Rhodiola rosea extract WS® 1375 in subjects with life-stress symptoms--results of an open-label study. Phytotherapy Research 26(8): 1220–1225, 2012
Cropley M, Banks AP and Boyle J. The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms. Phytother. Res. 29: 1934–1939, 2015
Parisi A et al. Effects of chronic Rhodiola Rosea supplementation on sport performance and antioxidant capacity in trained male: preliminary results. The Journal of Sports Medicine and Physical Fitness 50(1): 57-63, 2010
Shevtsov VA et al. A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine 10: 95–105, 2003
Noreen EE, Buckley JG, Lewis SL, Brandauer J, Stuempfle KJ. The effects of an acute dose of Rhodiola rosea on endurance exercise performance. J Strength Cond Res. 27(3): 839-47, 2013
Gerbarg PL, Brown RP. Pause menopause with Rhodiola rosea, a natural selective estrogen receptor modulator. Phytomedicine, Dec 12 2015
Thu OK, Spigset O, Nilsen OG, Hellum B. Effect of commercial Rhodiola rosea on CYP enzyme activity in humans. Eur J Clin Pharmacol, 2015
